← Open Payments lookup

KRISTIN WEBER: Open Payments

NPI 1487710067 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,288 in 30 payments from 18 companies in 2025. Trend: 2023 $13,588 · 2024 $2,965 · 2025 $4,288

Consulting: $3,776Food & beverage: $487Education: $25
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.3$2,183
BioCryst Pharmaceuticals, Inc.1$1,608
Cycle Pharmaceuticals Inc3$87
BioCryst US Sales Co., LLC4$48
LEO Pharma Inc.2$44
AstraZeneca Pharmaceuticals LP2$38
GlaxoSmithKline, LLC.2$32
Axsome Therapeutics, Inc.2$32
Baxter Healthcare1$32
ABBVIE INC.2$30

Products named: CUVITRU, ORLADEYO, Sajazir, TEZSPIRE, NUCALA, Symbravo, Hillrom - Vest System Model 105 Home Care, OCTAGAM IMMUNE GLOBULIN (HUMAN).

Industry payments across MN — which companies pay providers there.